Skip to main content
. 2010 Sep;12(5):629–635. doi: 10.2353/jmoldx.2010.090219

Table 3.

Comparison of Analytical Sensitivity for the Signature NPM1 Mutations Assay Alone or Combined with the Signature AML/ETO, inv(16)-ADE Primers and Probes

Signature NPM1 (MFI)*
Signature NPM1 + Signature AML/ETO, inv(16) ADE (MFI)*
NPM1-WT NPM1-Mut NPM1-WT NPM1-Mut Inv16-A Inv16-D Inv16-E AML1/ETO
No RNA 87 87 42 81 86 64 43 57
100% OCI-AML3 13,019 12,604 9745 10,719 110 67 83 64
HL-60 + 10% OCI-AML3 11,523 11,839 9745 10,263 65 44 77 92
HL-60 + 1% OCI-AML3 14,023 9097 10,579 7623 134 78 52 37
HL-60 + 0.1% OCI-AML3 14,025 4455 9881 3408 25 73 30 36
HL-60 + 0.01% OCI-AML3 13,745 1088 10,166 785 159 81 81 74
100% HL-60 12,465 159 9236 77 2 66 24 17
HL-60 + 2E+07 copies 10,980 12,416 10,388 11,638 97 87 102 144
HL-60 + 2E+06 copies 10,245 10,718 9108 10,432 115 134 127 97
HL-60 + 2E+05 copies 11,593 8566 10,564 8151 83 87 100 57
HL-60 + 2E+04 copies 11,511 4158 10,044 3033 112 79 140 82
HL-60 + 2E+03 copies 10,588 866 10,129 664 107 122 77 97
HL-60 + 2E+02 copies 11,287 322 10,352 190 88 104 78 91

Mut, mutant; WT, wild-type.

*

Values above the cutoff are in bold.